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A major site of pyridinoline cross-linking in bovine type IX collagen was traced to a tryptic peptide derived 
from one of the molecule's HMW chains. This peptide gave two amino acid sequences (in 2/1 ratio) con- 
sistent with it being a three-chained structure. The major sequence matched exactly that of the C-telopeptide 
of type II collagen from the same tissue. A second HMW chain that contained pyridinoline cross-links also 
gave two amino-terminal sequences, one from its own amino terminus, the other matching exactly the N- 
telopeptide cross-linking sequence of type II collagen. We conclude that type IX collagen molecules are co- 
valently cross-linked in cartilage to molecules of type II collagen, probably at fibril surfaces. 
Collagen; Cross-linking; Amino acid sequence; (Bovine cartilage) 
1. INTRODUCTION 
Hyaline cartilage contains at least three tissue- 
specific collagens, types II, IX and XI (lo~2cr3o~) 
[1]. Type II forms the tissue's fibrillar network, ac- 
counting for over 90°70 of the total collagen. Type 
IX collagen is an unusual molecule that consists of 
three triple-helical domains joined by short non- 
triple-helical sequences [2-7]. It accounts for 1-2°70 
of the collagen in adult hyaline cartilage and up to 
1007o in fetal cartilage. Pepsin solubilizes type IX 
collagen in the form of two main, pepsin-resistant 
fragments, HMW and LMW [3]. In chick cartilage 
one or two chondroitin sulfate or dermatan sulfate 
chains are attached per type IX collagen molecule, 
which therefore is also a type of proteoglycan 
[8-11]. Type IX collagen from bovine articular 
cartilage contains hydroxypyridinium (pyridino- 
line) cross-linking residues at a higher molar con- 
centration than found in type II collagen [12], 
making it one of the richest sources of these 
collagen-specific trivalent cross-links [13]. In the 
analyses described here, peptides were isolated and 
structurally characterized that originated from the 
hydroxypyridinium cross-linking sites in bovine 
type IX collagen. 
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III collagen chains; HPLC, high-performance liquid 
chromatography 
2. MATERIALS AND METHODS 
Type IX collagen was extracted by pepsin from 
2 year-steer articular cartilage and purified by salt 
precipitation [12]. The isolated protein was free of 
other collagens on SDS-polyacrylamide electro- 
phoresis. After reduction and carboxymethylation 
of cysteines, the HMW and LMW chain fragments 
of the type IX molecule were resolved by 
molecular-sieve column chromatography on 8% 
agarose (170 cm × 1.5 cm; Bio-Rad AI .5m, 
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00145793/87/$3.50 © 1987 Federation of European Biochemical Societies 337 
Volume 220, number 2 FEBS 
200-400 mesh) eluted with 1 M CaCI2, 0.05 M 
Tris-HCl, pH 7.5 [14]. Individual chains from the 
isolated HMW domain were resolved by reverse- 
phase HPLC on a macroporous C4-column 
(25 cm x 4.6 mm; Vydac 214TP54) eluted by a 
gradient of acetonitrile: n-propanol (3 : l, v/v) in 
aqueous 0.1°70 (v/v) trifluoroacetic acid. Tryptic 
peptides prepared from total HMW or from its in- 
dividual chains were resolved by a combination of 
molecular-sieve column chromatography on Bio- 
Gel P-10 (90 cmx 2.5 cm; 200-400 mesh; Bio- 
Rad) eluted in 10070 acetic acid, ion-exchange 
HPLC (DEAE5PW, 7.5 cm x 7.5 mm, Bio-Rad) 
with a linear NaCl-gradient in 0.02 M Tris-HCl, 
pH 7.5, and reverse-phase HPLC on a C18 column 
(25 cm x 4.6 mm; Vydac 218TP54) eluted with an 
acetonitrile gradient in aqueous 0.01 M n-hepta- 
fluorobutyric acid. Column effluents were 
monitored for polypeptide absorbance at 220 nm 
and specifically for the fluorescence of the hydrox- 
ypyridinium cross-linking amino acids (emission at 
395 nm; excitation at 297 nm for acid pH or 
330 nm for neutral pH [15]). 
Amino acid compositions were determined after 
hydrolysis in 6 M HC1 (24 h at 108°C) using pre- 
column derivatization with phenylisothiocyanate 
[16] and reverse-phase chromatography on a 
Brownlee Ultrasphere ODS column (25 cm × 
4.6 mm) using a Waters HPLC system. Peptides 
and chains were subjected to amino-terminal se- 
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Fig.1. Molecular-sieve column chromatography of the 
pepsin-generated domains of bovine type IX collagen on 
8o7o agarose (Bio-Rad AI-5m). The fluorescent 
pyridinoline cross-linking residues were recovered in the 
HMW fraction. 
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Fig.2. Reverse-phase HPLC (C-4 column) to resolve two 
chain fractions from HMW isolated by agarose 
chromatography (pooled as in fig.l). 
quencer using polybrene [17], and identifying the 
PTH amino acids by two different HPLC methods 
[18,19]. 
3. RESULTS 
Fig.1 shows the resolution by agarose column 
chromatography of pepsin-extracted and purified 
type IX collagen into its HMW and LMW chain 
fragments. All the cross-link-specific fluorescence 
was associated with HMW, as found by gel electro- 
phoresis [12]. 
The HMW fraction was resolved into two pro- 
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Fig.3. Reverse-phase HPLC (C-18 column) as the final 
purification step for the main HP-containing tryptic 
peptide (TI) from type IX collagen. (a) Fluorescent 
cross-linked peptides resolved from a trypsin digest of 
total HMW (fig. 1). (b) The fluorescent cross-linked pep- 
tide derived by trypsin from HMW2 (fig.2). 
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Table l 
Amino acid composition of tryptic peptide Tl derived 
from the main pyridinoline cross-linking site in type IX 
collagen 
Residues/peptide 
Hyp 3 (3.2) 
Asp 2 (1.6) 
Glu 5 (5.0) 
Pro 4 (3.9) 
Gly 9 (9.0) 
Ala 1 (1.3) 
Leu 3 (2.6) 
His 1 (1.0) 
Arg 2 (2.0) 
HP + LP a 1 (0.7) 
Total 31 
a Quantified on reverse-phase HPLC by 3-pyridinol 
fluorescence [23]. The ratio of HP to LP was about 4 
to 1 
(HMW1 and HMW2, fig.2), with 80% of the 
pyridinoline fluorescence in HMW2. A trypsin 
digest of the whole HMW fraction revealed one 
DERIVED FROM TYPE IX 
major fluorescent peptide on reverse-phase HPLC 
(Tl, fig.3a). The same fluorescent peptide was 
recovered from a trypsin digest of purified HMW2 
(fig.3b). 
The amino acid composition of the cross-linked 
tryptic peptide (table l) indicates 31 residues. 
Amino-terminal sequence analysis gave a major se- 
quence and a minor sequence indicating the partial 
structure shown in fig.4a. In comparison, fig.4b 
shows the structure of one of two main 
pyridinoline cross-linked peptides isolated, and se- 
quenced by similar methods, from a trypsin digest 
of pepsin-solubilized and purified bovine type II 
collagen from the same tissue (manuscript in 
preparation). The results indicate that two peptide 
arms of the type IX-derived cross-linked peptide 
and two peptide arms of the type II-derived cross- 
linked peptide have the same sequence. This se- 
quence comes from the C-telopeptide cross-linking 
domain of the crl(II)-chain by homology to the 
human and chick gene sequences [20]. 
The cross-linking residue could not be directly 
identified as a PTH derivative, its sites only in- 
ferred by blanks in the two running sequences. The 
DERIVED FROM TYPE II 
a). T1 tryptic peptide from HMW2. 
Gly-GIn-Arg-Glu- X -Gly-Pro-Asp 
Type II [ 
Gly-GIn-Arg-GIw X -Gly-Pro-Asp 
I 
Type IX His-Gly-Ala-Hyp-Gly-Glu- X -Gly-(Pro-Leu) ..... 
b). Tryptic peptide (C - telopeptides to helix ). 
13 c 20 c 
c~l(ll) Gly-GIn-Arg-Glu- X -Gly-Pro-Asp 
I 
cO01) Gly-GIn-Arg-Glu- X -Gly-Pro-Asp 
/ 
I 
ctl(ll) Gly-Phe-Hyp-Gly-Thr-Hyp-Gly-Leu-Hyp-Gly-Val- X -Gly-His-Arg 
87 
c). HMW1 polypeptide. 
Asp-Glu- X -Ala-Gly-Gly-Ala-GIn 
Type II I 
Asp-Glu- X -Ala-Gly-Gly-Ala-GIn 
L 
] 
Type IX Phe-Leu-Cys-Pro-Thr-Asn-Cys-Pro-Ala-Gly-Val Hyp......X ...... 
I~t Chicken ] 
~(IX) Pro-Leu-Cys-Pro-Asn-Ala-Cys- Pro-Pro-Gly-Arg-Pro from [6].J 
d). Tryptic peptide (N - telopeptides to helix ). 
7N 14 N 
Ctl (11) Asp-Glu- X -Ala-Gly-Gly-Ala-GIn 
I 
ctl (11) Asp-Glu- X -Ala-Gly-Gly-Ala-GIn 
I 
or1 (11) Gly-Leu- X -Gly-His-Arg 
93O 
Fig.4. Amino-terminal structures deduced from the Edman degradation of cross-linked peptides purified from types 
IX and II collagens of bovine articular cartilage. (a). TI tryptic peptide (fig.3) from the main cross-linking site in type 
IX collagen (HMW2 chain fraction). (b) The major cross-linked tryptic peptide from type II collagen (C-telopeptide 
site). (c) Deduced amino-terminal sequences for the HMWI chain fraction (fig.2). (d) The major cross-linked tryptic 
peptide from type II collagen (N-telopeptide site). The amino termini of the type II telopeptide sequences are created 
by the pepsin-digestion needed to solubilize the collagens. 
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3-pyridinol ring structure, and hence the potential- 
ly detectable fluorescence of HP and LP (the two 
structural forms of pyridinoline cross-linking 
residue), was destroyed by the cycles with 0.1 M 
Quadrol, pH 9.2, at 52°C in the spinning cup (the 
half-life of HP was about 40 min under these con- 
ditions). 
Direct amino-terminal sequence analysis on the 
second resolved popypeptide from the HMW 
triple-helix (HMWl,  fig.2), which gave a single 
band on SDS-polyacrylamide electrophoresis (not 
shown), again revealed two sequences which are in- 
terpreted as shown in fig.4c. One of the sequences 
is identical to that found on two arms of the other 
major cross-linked peptide derived from pure type 
II collage n (fig.4d), which comes from the N-telo- 
peptide cross-linking domain of the od(II)-chain 
by homology to the rat gene sequence [21]. This 
second HMW chain, therefore, apparently also 
contains a site of cross-linking which can link to 
the N-telopeptide domain of type II collagen. Its 
deduced amino-terminal sequence shows simila- 
rities (fig.4c), notably in the placement of cys- 
teines, to the chick ~l(IX)-chain over the sequence 
that spans the junction of the non-collagenous 
(NC3) and the main collagenous (COL2) domains 
of HMW [6]. 
4. DISCUSSION 
The results provide direct evidence that mole- 
cules of type IX collagen are covelantly cross- 
linked in cartilage to molecules of type II collagen 
through the hydroxylysine-aldehyde mediated 
mechanism [13]. The sequence data imply that 
telopeptide aldehydes on type II collagen can link 
to the type IX collagen molecule at one or more 
sites on at least two chains of its COL2 triple- 
helical domain [7]. The mature cross-linking struc- 
tures are trivalent pyridinoline residues which are 
also the main aldehyde-mediated intermolecular 
cross-links within type II collagen fibrils. Their 
mechanism of formation is uncertain, for example 
whether the two telopeptide arms on each 
pyridinoline residue derive from one or two type II 
collagen molecules. In the T1 tryptic peptide, 
which consists of two type II C-telopeptides linked 
to a sequence from the type IX triple-helix (COL2 
domain [7]), it is not yet certain which re-chain this 
latter peptide derives from in terms of the oel(IX)-, 
c~2(IX)- and ce3(IX)-chains of chick type IX col- 
lagen [10]. 
The sequencing results on the HMWl polypep- 
tide (the lesser source of pyridinoline cross-links) 
indicate that it consists of one chain from the 
COL2 domain of the type IX collagen molecule 
that carries N-telopeptides from type II collagen 
covalently linked to a hydroxylysine r sidue some- 
where along it. 
These conclusions imply that individual type IX 
collagen molecules function in cartilage matrix in 
covalent linkage to type II collagen molecules 
probably located on the surface of fibrils. Indeed, 
immunogold electronmicroscopic lo alization has 
shown that type IX collagen decorates the surface 
of type II collagen fibrils in chick cartilage, par- 
ticularly where fibrils intersect [22]. Having at least 
two sites for cross-linking to type II collagen, the 
type IX collagen molecule has the potential, there- 
fore, to bridge fibrils covalently. If it so functions, 
type IX collagen could profoundly influence the 
material and biological properties of cartilage. It 
may act as a 'fusible link' that is cleavable by pro- 
teases (or perhaps mechanical forces) to permit 
normal growth and remodelling, and possibly to 
initiate the swelling and lost cohesiveness of ar- 
ticular cartilage seen in osteoarthritis. 
If bovine type IX collagen is a type of proteo- 
glycan as it is in the chick [8-11], the glycosamino- 
glycan chains may have the function of targeting 
the molecule to the correct sites for cross-linking 
on type II fibril surfaces. It is also possible, 
however, that the principal function of type IX 
collagen is to adapt the physical properties of type 
II fibril surfaces to their intimate nmeshment with 
proteoglycans. 
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NOTE ADDED IN PROOF 
The first eight residues of the bovine type IX 
chain shown in fig. 4c match exactly a sequence 
recently reported for this domain of the chicken 
a2(IX) chain ]McCormick et al. (1987) Proc. Natl. 
Acad. Sci. USA 84, 4044-4048]. 
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